Improved LCP Tacrolimus Dosing and Monitoring Outcomes With a Genotype‐Based Dosing Algorithm Versus Weight Based Dosing
Clinical Transplantation · 2025-11 · 39 (11)
DOI: 10.1111/ctr.70363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 31.10.2025. Verfasst von Christine S Wolesensky und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Graft Rejection, Kidney Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
The aim of this study was to assess the impact of CYP3A5 genotype‐based LCP tacrolimus (tac) versus weight‐based dosing among adult kidney transplant recipients. This was a retrospective longitudinal matched cohort analysis. From February 2021 to June 2023, LCP tac was dosed using standard weight‐based dosing. Starting in June 2023, genotype‐based dosing was used; 148 patients were included (74 in each arm). Baseline characteristics were well balanced between the groups, except for age (control 46 ± 14 vs. 52 ± 14 years, p < 0.01); 32% were females, 36% were African American, 84% were living donors, 40% had DM, and 10% had DGF. At 90‐days post‐txp, the genotype guided cohort had an average of two fewer tacrolimus dose adjustments per patients (4 vs. 6, p < 0.0001), spent longer time in therapeutic range (59% vs. 47%, p = 0.004), and less time in concerning range (9% vs. 18%, p < 0.0001). Acute rejection, de novo donor specific antibodies, and eGFR was similar between the two cohorts. This matched cohort analysis assessing a genotype‐based dosing algorithm demonstrated improved LCP tac dosing efficiency. Patients on average, needed two fewer dose adjustments, spent longer time in therapeutic range and had significantly less time in concerning range.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Medical University of South Carolina, Charleston, South Carolina, USA.
- Deaprtment of Transplant Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
ORCID-Profile: Christine S Wolesensky, Neha Patel, Santosh Nagaraju, David J Taber
Zitieren
APA
Wolesensky, C. S., Patel, N., Nagaraju, S., Hanish, S., Roberts, M., Dorsett, M., & Taber, D. J. (2025). Improved LCP Tacrolimus Dosing and Monitoring Outcomes With a Genotype‐Based Dosing Algorithm Versus Weight Based Dosing. Clinical Transplantation, 39(11). https://doi.org/10.1111/ctr.70363
Vancouver
Wolesensky CS, Patel N, Nagaraju S, Hanish S, Roberts M, Dorsett M, et al. Improved LCP Tacrolimus Dosing and Monitoring Outcomes With a Genotype‐Based Dosing Algorithm Versus Weight Based Dosing. Clinical Transplantation. 2025;39(11). doi:10.1111/ctr.70363
BibTeX
@article{Wolesensky2025,
author = {Wolesensky, Christine S and Patel, Neha and Nagaraju, Santosh and Hanish, Steve and Roberts, Morgan and Dorsett, Margaret and Taber, David J},
title = {Improved LCP Tacrolimus Dosing and Monitoring Outcomes With a Genotype‐Based Dosing Algorithm Versus Weight Based Dosing},
journal = {Clinical Transplantation},
year = {2025},
volume = {39},
number = {11},
doi = {10.1111/ctr.70363}
}
EUVIMED